aminolevulinic acid has been researched along with Atypical Lipomatous Tumor in 1 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Excerpt | Relevance | Reference |
---|---|---|
"In this context, we, for the first time, assessed 5-aminolevulinic acid (5-ALA)-PDT-mediated anti-cancer activity and its molecular mechanism after continuous wave (CW) and pulse radiation (PR) on three different histological types (liposarcoma, chondrosarcoma, and osteosarcoma) of CMST cells by WST-1, Annexin V, ROS, acridine orange/propidium iodide staining, RT-PCR, and western blot analysis." | 8.31 | Comparison of the anti-cancer activity of 5-aminolevulinic acid-mediated photodynamic therapy after continuous wave and pulse irradiation in different histological types of canine mammary sarcoma tumors. ( Armutak, EI; Baykal, A; Deveci Ozkan, A; Guney Eskiler, G; Kaleli, S; Kamanli, AF; Kasikci, G; Lim, HS; Ozten, O; Turna, O; Yildirim, F; Yildiz, SZ, 2023) |
"In this context, we, for the first time, assessed 5-aminolevulinic acid (5-ALA)-PDT-mediated anti-cancer activity and its molecular mechanism after continuous wave (CW) and pulse radiation (PR) on three different histological types (liposarcoma, chondrosarcoma, and osteosarcoma) of CMST cells by WST-1, Annexin V, ROS, acridine orange/propidium iodide staining, RT-PCR, and western blot analysis." | 4.31 | Comparison of the anti-cancer activity of 5-aminolevulinic acid-mediated photodynamic therapy after continuous wave and pulse irradiation in different histological types of canine mammary sarcoma tumors. ( Armutak, EI; Baykal, A; Deveci Ozkan, A; Guney Eskiler, G; Kaleli, S; Kamanli, AF; Kasikci, G; Lim, HS; Ozten, O; Turna, O; Yildirim, F; Yildiz, SZ, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Turna, O | 1 |
Deveci Ozkan, A | 1 |
Guney Eskiler, G | 1 |
Baykal, A | 1 |
Ozten, O | 1 |
Yildirim, F | 1 |
Armutak, EI | 1 |
Kamanli, AF | 1 |
Lim, HS | 1 |
Kaleli, S | 1 |
Kasikci, G | 1 |
Yildiz, SZ | 1 |
1 other study available for aminolevulinic acid and Atypical Lipomatous Tumor
Article | Year |
---|---|
Comparison of the anti-cancer activity of 5-aminolevulinic acid-mediated photodynamic therapy after continuous wave and pulse irradiation in different histological types of canine mammary sarcoma tumors.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Cell Line, Tumor; Chondrosarcoma; Dogs; Liposarcoma; Photoc | 2023 |